|
- 积分
- 279
- 威望
- 279
- 包包
- 128
|
Title: CD133: molecule of the moment.$ T. L8 ]6 k' E+ w. L9 L ~
Author: Mizrak, D.; Brittan, M.; Alison, M. R.
' I) p" w# g9 Y4 A4 ^; t+ kSource: J Pathol, 2008, 214(1): 3-9* w* p' l/ X- J" R: i4 W2 R; V
( i- o6 M* g. F OTitle: Focus on molecules: prominin-1 (CD133).' E& D% r2 L/ p0 P) @& I
Author: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)
9 f+ x+ g+ j( W8 Q5 Q. h2 ISource: Exp Eye Res, 2007, 85(5): 585-586. W1 W- g# i4 b8 o- @* w6 y+ b
8 ]% i# f% L8 C# |5 z$ MTitle: CD133.
- w: M# t* f; K! qAuthor: Piechaczek, C.: J) i' p6 d1 A/ {/ S X9 b& Q
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-102
! A4 u2 x& f2 [7 o* w2 H6 N
, v( V+ _5 d) Q* RTitle: CD133 as a marker for cancer stem cells: progresses and concerns.
8 ]) ^$ a* p V Q% F7 BAuthor: Wu, Y.; Wu, P. Y.& m1 A" G, s2 X: Q
Source: Stem Cells Dev, 2009, 18(8): 1127-1134
5 y3 R8 @8 u! b6 d- X% t: s* Y6 D: K& ?
Title: Risk and benefit of CD133+ progenitors.% W' ]# c' F. |2 D- P6 |$ P
Author: Ascione, R.; Madeddu, P.. c9 e2 W4 a. w1 R9 G
Source: Circ Res, 2009, 105(2): e2
3 E H$ p: \) K* Y; j2 f& [- q3 M: v `1 H( C
Title: Targeting CD133 antigen in cancer.
7 K5 z, V1 l' K* i- `8 |Author: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...)) }3 b2 v+ W4 F$ Z$ y! K6 [% \7 r
Source: Expert Opin Ther Targets, 2009, 13(7): 823-837- h# s# G, w2 g$ C7 s4 t' P
2 i! t' u$ M9 G3 _8 g. [1 [8 J8 b: Q7 WTitle: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
* I% f$ r5 G( f( nAuthor: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)2 j' a3 W1 j$ Y; q
Source: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|
发表于 2010-7-9 14:12
发表于 2010-7-9 22:47
rogresses and Concerns不好意思，没看到楼上的已经发了这一篇